Amylyx ALS drug fails crucial study, putting company’s future in doubt
BioPharma Dive » Clinical Trials
by
1w ago
The results have led Amylyx to pause promotion of Relyvrio and potentially pull it from the market in the coming weeks, a major blow to the company and ALS patients ..read more
Visit website
Amylyx CEOs look for a path forward following major setback
BioPharma Dive » Clinical Trials
by
1w ago
Justin Klee and Joshua Cohen spoke to BioPharma Dive about the next steps for their company, which is considering pulling its only product from market after the drug failed a confirmatory study in ALS ..read more
Visit website
Roche, following setbacks, turns to its next Alzheimer’s drug
BioPharma Dive » Clinical Trials
by
1w ago
Roche said its experimental Alzheimer’s disease drug trontinemab showed it might be able to clear brain plaques faster than other medicines ..read more
Visit website
Acadia drug fails schizophrenia trial, setting back company’s expansion plans
BioPharma Dive » Clinical Trials
by
1w ago
The setback shuts out Acadia’s top medicine from a large sales opportunity and heightens the biotech’s dependence on a pipeline filled with risky drug prospects.  ..read more
Visit website
Merck reveals plans to develop newer HPV shots
BioPharma Dive » Clinical Trials
by
1w ago
The pharma intends to test a single-dose regimen as well as a shot that may provide broader protection than the current versions of Gardasil that regularly generate billions in annual sales ..read more
Visit website
Minerva schizophrenia drug rejected by FDA
BioPharma Dive » Clinical Trials
by
3w ago
The agency’s complete response letter knocks back Minerva’s attempt to secure approval of the drug over agency reviewers’ objections ..read more
Visit website
Viking data suggest obesity drug could rival Zepbound, Wegovy
BioPharma Dive » Clinical Trials
by
3w ago
The biotech’s drug led to significant weight loss in a Phase 2 trial, causing shares to double as analysts compared results to the marks set by drugs from Eli Lilly and Novo Nordisk ..read more
Visit website
Janux shares triple on early cancer immunotherapy data
BioPharma Dive » Clinical Trials
by
3w ago
Analysts viewed results for one of Janux’s drug, a T cell engager aimed at metastatic prostate cancer, as potentially best-in-class in a field that’s crowded with competitors ..read more
Visit website
Using knowledge graphs to drive drug discovery
BioPharma Dive » Clinical Trials
by
3w ago
How are knowledge graphs changing the path of drug discovery ..read more
Visit website
Akero strengthens MASH drug’s case with new study data
BioPharma Dive » Clinical Trials
by
3w ago
The updated results show that responses to the drug, which is currently in late-stage testing, deepened with time, helping the company rebound from an earlier setback ..read more
Visit website

Follow BioPharma Dive » Clinical Trials on FeedSpot

Continue with Google
Continue with Apple
OR